Compare Iris Energy Limited (IREN) vs Repligen Corporation Common Stock (RGEN) Price & Performance

IREN trades at $34.80, showing no change in the last 24 hours. The stock faces bearish technical signals despite bullish oscillators, with key support at $34. Recent earnings misses and a negative net income margin of -99.38% highlight financial strain, though revenue grew to $501M in 2025. Analyst sentiment remains strongly positive with a consensus price target of $81.00, driven by the company's pivot to AI infrastructure and major contracts with Microsoft and NVIDIA.

The outlook is bifurcated: substantial upside exists if IREN executes its AI transition, but high valuation ratios and persistent losses pose risks. Investors should weigh the aggressive growth projections against current profitability challenges and capital intensity.

RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.

Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.